Citadel Advisors’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12M | Buy |
603,653
+167,911
| +39% | +$3.34M | ﹤0.01% | 1257 |
|
|
2025
Q1 | $7.36M | Buy |
435,742
+209,123
| +92% | +$3.53M | ﹤0.01% | 1472 |
|
|
2024
Q4 | $4.19M | Sell |
226,619
-76,299
| -25% | -$1.41M | ﹤0.01% | 1942 |
|
|
2024
Q3 | $6.58M | Buy |
302,918
+116,683
| +63% | +$2.54M | ﹤0.01% | 1551 |
|
|
2024
Q2 | $3.65M | Buy |
186,235
+73,796
| +66% | +$1.45M | ﹤0.01% | 1927 |
|
|
2024
Q1 | $2.44M | Sell |
112,439
-10,441
| -8% | -$227K | ﹤0.01% | 2320 |
|
|
2023
Q4 | $3.55M | Sell |
122,880
-70,136
| -36% | -$2.03M | ﹤0.01% | 1918 |
|
|
2023
Q3 | $5.16M | Sell |
193,016
-271,406
| -58% | -$7.26M | ﹤0.01% | 1594 |
|
|
2023
Q2 | $17.2M | Buy |
464,422
+166,247
| +56% | +$6.16M | ﹤0.01% | 897 |
|
|
2023
Q1 | $9.31M | Buy |
298,175
+240,849
| +420% | +$7.52M | ﹤0.01% | 1358 |
|
|
2022
Q4 | $1.71M | Sell |
57,326
-107,467
| -65% | -$3.2M | ﹤0.01% | 2706 |
|
|
2022
Q3 | $6.28M | Buy |
164,793
+42,057
| +34% | +$1.6M | ﹤0.01% | 1666 |
|
|
2022
Q2 | $6.69M | Buy |
122,736
+61,468
| +100% | +$3.35M | ﹤0.01% | 1598 |
|
|
2022
Q1 | $3.82M | Sell |
61,268
-167,624
| -73% | -$10.5M | ﹤0.01% | 2324 |
|
|
2021
Q4 | $23M | Sell |
228,892
-28,528
| -11% | -$2.87M | ﹤0.01% | 855 |
|
|
2021
Q3 | $23.2M | Buy |
257,420
+243,672
| +1,772% | +$21.9M | ﹤0.01% | 823 |
|
|
2021
Q2 | $1.27M | Sell |
13,748
-144,784
| -91% | -$13.4M | ﹤0.01% | 3718 |
|
|
2021
Q1 | $15.3M | Buy |
158,532
+146,623
| +1,231% | +$14.2M | ﹤0.01% | 1114 |
|
|
2020
Q4 | $620K | Buy |
11,909
+1,723
| +17% | +$89.7K | ﹤0.01% | 3690 |
|
|
2020
Q3 | $408K | Buy |
+10,186
| New | +$408K | ﹤0.01% | 3648 |
|